The economic burden of common adverse events associated with metastatic colorectal cancer treatment in the United States
The economic burden of common adverse events associated with metastatic colorectal cancer treatment in the United States is a paper indexed in ScholarIQ from OpenAlex.
How many citations does The economic burden of common adverse events associated with metastatic colorectal cancer treatment in the United States have?
The economic burden of common adverse events associated with metastatic colorectal cancer treatment in the United States has 21 citations in the OpenAlex counts ScholarIQ stores.
When was The economic burden of common adverse events associated with metastatic colorectal cancer treatment in the United States published?
The economic burden of common adverse events associated with metastatic colorectal cancer treatment in the United States has 2016 year in the ScholarIQ index.
What is the open-access status of The economic burden of common adverse events associated with metastatic colorectal cancer treatment in the United States?
The economic burden of common adverse events associated with metastatic colorectal cancer treatment in the United States has bronze oa status in the ScholarIQ index.
What is the DOI of The economic burden of common adverse events associated with metastatic colorectal cancer treatment in the United States?
The DOI for The economic burden of common adverse events associated with metastatic colorectal cancer treatment in the United States is on the source record.
What is the PMID of The economic burden of common adverse events associated with metastatic colorectal cancer treatment in the United States?
The PMID for The economic burden of common adverse events associated with metastatic colorectal cancer treatment in the United States is on the source record.
What is the OpenAlex record for The economic burden of common adverse events associated with metastatic colorectal cancer treatment in the United States?
The OpenAlex for The economic burden of common adverse events associated with metastatic colorectal cancer treatment in the United States is on the source record.